簡易檢索 / 詳目顯示

研究生: 錢宏旻
論文名稱: 使用磁減量免疫檢測方法進行 多重肝癌指標蛋白之檢測
Examination of multiple liver cancer biomarkers by Immunomagnetic Reduction assay
指導教授: 洪姮娥
Horng, Herng-Er
謝振傑
Chieh, Jen-Jie
學位類別: 碩士
Master
系所名稱: 光電工程研究所
Graduate Institute of Electro-Optical Engineering
論文出版年: 2013
畢業學年度: 101
語文別: 中文
論文頁數: 53
中文關鍵詞: 肝癌指標蛋白磁性奈米粒子磁性生物標記披覆多重抗體試劑
論文種類: 學術論文
相關次數: 點閱:108下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 現今是以Alpha-fetoprotein(AFP)針對肝細胞癌的高危險族群做為肝癌篩檢的指標,約 70% 的肝癌患者AFP 會明顯上升;但由於AFP只有70%的檢測率,對於我們想要早期發現早期治療尚有難度,因此我們希望利用更多種的肝癌指標蛋白來做檢測,藉此可以提高肝癌檢測的靈敏度。
    在此研究中我們將Alpha-fetoprotein(AFP),Glypican3(GPC3),Des gamma carboxy prothrombin(DCP) 等抗體與磁性奈米粒子結合,形成具有磁性生物標記(magnetic bio – marker)之三種不同肝癌指標之磁性試劑(magnetic reagent);同時我們也開發出將AFP、GPC3、DCP三種抗體混合後在將混合抗體與磁性奈米粒子結合形成新的披覆多重抗體試劑(Multiple Coating);最後,再利用本實驗室所研發之磁減量檢測法(Immunomagnetic rednction ; IMR)以及顯微鏡以及ELISA等實驗器材,探討磁性試劑的特性,並與臨床檢測常用的酵素連結免疫吸附分析來進行比較;以及利用混合試劑量測混合標準抗原,探討其檢測標準值。

    第一章 緒論.......................................1 第二章 免疫檢測方法..................................3 2.1磁減量免疫檢測( Immunomagnetic reduction ; IMR)..3 2.2 臨床使用的免疫檢測方法...........................7 第三章 磁性試劑的製程與特性探討......................11 3.1 磁性試劑的製程...............................11 3.2 磁性試劑的特性探討............................18 第四章 肝癌抗原的檢測...............................27 4.1以磁減量免疫檢測方法檢測單一肝癌抗原..............27 4.2 比較不同檢測方法檢測單一肝癌抗原................37 4.3 以磁減量免疫檢測方法檢測多重肝癌抗原.............47 第五章 結論.......................................49 文獻 ............................................50 致謝

    1. 行政院衛生署國民健康局98年度癌症登記資料報告
    2. 楊溢,陳其云,楊揚等.免疫比濁法測定血清C-反應蛋白(CRP)的評價.四川省衛生管理幹部學院學報,22, 165-166,2003.
    3. C.Y. Hong, C.C. Wu, Y.C. Chiu, S.Y. Yang, H.E. Horng, and H.C. Yang, Appl. Phys. Lett. 88, 212512, 2006.
    4. National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Primary Liver Cancer (2011)
    5. TATARINOV IuS. DETECTION OF EMBRYO-SPECIFIC ALPHA-GLOBULIN IN THE BLOOD SERUM OF A PATIENT WITH PRIMARY LIVER CANCER. Vopr Med Khim. Jan-Feb;10:90-1,1964
    6. Franco Trevisani1, Paola Emanuela D'Intino1, Antonio Maria Morselli-Labate2,Giuseppe Mazzella2, Esterita Accogli2, Paolo Caraceni1, Marco Domenicali1,Stefania De Notariis1, Enrico Roda2,.Journal of Hepatology 34 , 570±575,2001
    7. Jakubovic BD, Jothy S. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma. Exp Mol Pathol. Apr;82(2):184-9,2007
    8. Sung YK, Hwang SY, Park MK, Farooq M, Han IS, Bae HI, Kim JC, Kim M. Cancer Sci. Mar;94(3):259-62,2003
    9. Z-W Zhu, H Friess, L Wang, M Abou-Shady, A Zimmermann, A D Lander, M Korc,J KleeV, M W Büchler. Gut 2001;48:558–564
    10. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J. Gastroenterology. Jul;125(1):89-97,2003
    11. Chaur-Shine Wang, Chih-Lin Lin, Hsi-Chang Lee, Kuan-Yang Chen, Ming-Feng Chiang, Hung-Sheng Chen, TsungJung Lin, Li-Ying Liao World J Gastroenterol;11(39):6115-6119,2005
    12. Fujiyama S, Izuno K, Yamasaki K, Sato T, Taketa K. Tumour Biol. 13(5-6):316-23,1992
    13. Kasahara A, Hayashi N, Fusamoto H, Kawada Y, Imai Y, Yamamoto H, Hayashi E, Ogihara T, Kamada T. Dig Dis Sci. Dec; 38(12): 2170-6, 1993
    14. Grazi GL, Mazziotti A, Legnani C, Jovine E, Miniero R, Gallucci A, Palareti G, Gozzetti G. Liver Transpl Surg. Jul;1,4:249-55,1995
    15. J. Bauer, J. Chromatography B: Biomedical Sciences and Applications, 722, 55,1999
    16. P.J. Fisher, M.J. Springett, A.B. Dietz, P.A. Bulur, and S. Vuk-Pavlovic, J. Immunological Methods, 262, 95,2002.
    17. W.Q. Jiang, H.C. Yang, S.Y. Yang, H.E. Horng, J.C. Hung, Y.C. Chen, and Chin-Yih Hong, J. Magn. Magn. Mater., 283, 210,2004.
    18. H. E. Horng, S. Y. Yang, Y. W. Huang, W. Q. Jiang, C.-Y. Hong, and H.C. Yang, IEEE Trans. Appl. Supercond., 15, 668,2005.
    19. H.E. Horng, Chin-Yih Hong, S.Y. Yang, H.C. Yang, S.H. Liao, C.M. Liu, and C.C. Wu, J. Korean Phys. Soc., 48, 999,2006.
    20. K.W. Huang, S.Y. Yang, Y.W. Hong, J.J. Chieh, C.C. Yang, H.E. Horng*, C.C. Wu*, C.Y. Hong, and H.C. Yang, “Feasibility studies for assaying alpha-fetoprotein using antibody- activated magnetic nanoparticles,” International Journal of Nanomedicine, 1991–1996, 2012
    21. H. C. Yang, S. Y. Yang, S. H. Liao, G. L. Fang, W. H. Huang, C. H. Liu, H. E. Horng, and Chin-Yih Hong, J. Appl. Phys. 99, 124701 ,2006.
    22. H.E. Horng, S.Y. Yang, Y.W. Huang, W.Q. Jiang, C.Y. Hong, and H.C. Yang, IEEE Trans. Appl. Supercond. 15, 668 (2005).
    23. H.J. Krause, N. Wolters, Y. Zhang, A. Offenhäusser, P. Miethe, M.H.F. Meyer, M. Hartmann, and M. Keusgen, J. Magn. Magn. Mater. 311, 436 ,2007.
    24. R. A. Goldsby, T. J. Kindt, B. A. Osborne, J. Kuby, FREEMAN,Immunology, New York
    25. Abrahom, GE. Handbook of Radioimmunoassay. New York:and Basel, 1977
    26. T.Rheinländer , R. Kötitz, W. Weitschies,W. Semmler, Journal of Magnetism and Magnetic Materials, 219, 219,2000.
    27. H.E. Horng, S.Y. Yang, ,C.Y. Huang , H.T. Chan, Y.Y. Do, P.L. Huang, , P.L. Chien, T.S. Chan, R.S. Liu Journal of Magnetism and Magnetic Materials 304,e415–e417, 2006
    28. http://cht.a-hospital.com/w/%E8%91%A1%E8%81%9A%E7%B3%96#.UeZNhNJkMix(葡聚糖)
    29. S.Y. Yang ,C.S. Ho b , C.L. Leea , B.Y. Shih , H.E. Horng,, Chin-Yih Hong , H.C. Yang , Food Chemistry 131, 1021–1025 ,2012
    30. C.Y. Hong, S.Y. Yang, K. W. Huang, H.E. Horng ,H.C. Yang. No. DETC47178, pp. 11-15,2011

    無法下載圖示 本全文未授權公開
    QR CODE